Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT06672523
Phase 1
Recruiting
A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion
Hungary, Spain
NCT07492680
Phase 2
Not yet recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
United States, Belgium, Canada, China, France, Germany, Hong Kong, Ireland, Ital